AzTrials
AzTrials

StillbirthSPiRENCT03231007

Saving Babies' Lives Project Impact and Results Evaluation: a Mixed Methodology Study

An observational study of Stillbirth, run by University of Manchester at 20 sites in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study is a multicentre evaluation of maternity care delivered through the Saving Babies' Lives care bundle using both quantitative and qualitative methodologies. The study will be conducted in twenty NHS Hospital Trusts from six NHS Strategic Clinical Networks totalling approximately 100,000 births. Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Stillbirth
What is being tested?
Questionnaire
How many people
4,952 participants
Where
20 sitesUnited Kingdom
Study dates
10 Jul 2017to 5 Jul 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • Child, Adult, Older adult

Study population: Postnatal service users who have received antenatal care and given birth in one of the 20 study sites. Healthcare professionals who are involved in delivering maternity care in one of the 20 study sites.

Who may be able to join

  • Women who received their antenatal care, delivered and were discharged from the same maternity unit
  • Women who have given birth after 28 weeks of gestation
  • Midwives working before and after implementation of the care bundle (including antenatal ward, antenatal clinic, community-based staff, antenatal assessment unit and labour ward)
  • Community midwives working before and after implementation of the care bundle
  • Sonographers working before and after implementation of the care bundle
  • Junior doctors working before and after implementation of the care bundle
  • Consultant obstetricians working before and after implementation of the care bundle
  • Clinical Directors and Heads of Midwifery working before and after implementation of the care bundle

Who cannot join

  • Maternal age ≤ 16 years
  • Individuals who cannot understand/not fluent in English (to enable consent without interpreter)
  • Multiple pregnancy
  • Fetuses known to have any congenital or severe structural abnormalities
  • Home births
  • Staff who were employed after the care bundle was implemented

Trial locations and contacts

20 sites in 1 country.

20 sites in 1 country

United Kingdom20 sites
  • Barnsley Hospital NHS Foundation Trust

    Barnsley

  • Royal United Hospitals Bath NHS Foundation Trust

    Bath

  • Birmingham Women's and Children's NHS Foundation Trust

    Birmingham

  • North Bristol NHS Trust

    Bristol

  • North Cumbria University Hospitals NHS Trust

    Carlisle

  • Countess of Chester Hospital NHS Foundation Trust

    Chester

  • Doncaster and Bassetlaw Hospitals NHS Foundation Trust

    Doncaster

  • Royal Devon & Exeter NHS Foundation Trust

    Exeter

  • Gateshead Health NHS Foundation Trust

    Gateshead

  • Oxford University Hospitals NHS Trust

    Headington

  • Hull and East Yorkshire Hospital NHS Trust

    Hull

  • University Hospitals of Morecambe Bay NHS Foundation Trust

    Kendal

  • Liverpool Women's NHS Foundation Trust

    Liverpool

  • Central Manchester University Hospitals NHS Foundation Trust

    Manchester

  • Plymouth Hospital NHS Trust

    Plymouth

  • St Helens and Knowsley Teaching Hospitals NHS Trust

    Prescot

  • Sherwood Forest Hospitals NHS Foundation Trust

    Sutton in Ashfield

  • Taunton and Somerset NHS Foundation Trust

    Taunton

  • The Mid Yorkshire Hospitals NHS Trust

    Wakefield

  • York Teaching Hospital NHS Foundation Trust

    York

Other trials in United Kingdom

About this study

The study is a multicentre evaluation of maternity care delivered through the Saving Babies' Lives care bundle using both quantitative and qualitative methodologies. The study will be conducted in twenty NHS Hospital Trusts from six NHS Strategic Clinical Networks totalling approximately 100,000 births. It involves participation by both service users and care providers.

To determine the impact of the care bundle on pregnancy outcomes, birth data and other clinical measures will be extracted from maternity databases and case-note audit from before and after implementation. Additionally, this study will employ questionnaires with organisational leads and review clinical guidelines to assess how resources, leadership and governance may affect implementation in diverse hospital settings. The cost of implementing the care bundle, and the cost per stillbirth avoided, will also be estimated as part of a health economic analysis. The views and experiences of service users and service providers towards maternity care in relation to the care bundle will be also be sought using questionnaires.

This study will provide practice-based evidence to advance knowledge about the processes that underpin successful implementation of the care bundle so that it can be further developed and refined. This has the potential to translate into substantial improvements in the rate of late stillbirth in the UK should the care bundle be proved effective.

Read the detailed description

Reducing stillbirth and early neonatal death is a national priority. Best practice and key evidence indicates this is potentially achievable through application of four key interventions within routine maternity care delivered as NHS England's Saving Babies' Lives care bundle. However, adoption of the care bundle by UK maternity services is still in its infancy and there is significant variation in the degree of implementation between and within units. The effectiveness of the care bundle, when implemented as a package, in reducing stillbirth and service delivery has not yet been evaluated. This study aims to evaluate the impact of implementing the care bundle on UK maternity services and perinatal outcomes.

Conditions
Stillbirth
Being tested
Questionnaire
Medical subject headings
Stillbirth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireOther

    A structured questionnaire will be administered to maternity service users. Another structured questionnaire will be administered to maternity healthcare professionals, and another to Organisational Leads (e.g. Clinical Directors at each site).

Study groups in NCT03231007
Study groupRoleWhat they receive
InnovatorsMaternity units that implemented the Care Bundle to the highest level (according to an NHS survey in 2015) are categorised as 'Innovators'.
Receives: Other: Questionnaire
Early AdoptersMaternity units that implemented the Care Bundle to the second-highest level (according to an NHS survey in 2015) are categorised as 'Early Adopters'.
Receives: Other: Questionnaire
Late AdoptersMaternity units that implemented the Care Bundle to the third-highest level (according to an NHS survey in 2015) are categorised as 'Late Adopters'.
Receives: Other: Questionnaire
Low AdoptersMaternity units that implemented the Care Bundle to the fourth-highest level (according to an NHS survey in 2015) are categorised as 'Low Adopters'.
Receives: Other: Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stillbirths

    All stillbirths (singletons and multiples). Stillbirths will be defined according to the UK definition as the death of a baby before or during birth after 24 weeks of gestation.

    Measured: 1st April 2012-1st October 2017

Secondary outcomes (13)
  1. Term, normally formed singleton stillbirths (antepartum and intrapartum).

    This excludes issues of preterm birth and major mortality and morbidity associated with congenital anomalies.

    Measured: 1st April 2012-1st October 2017

  2. Preterm births

    Measured: 1st April 2012-1st October 2017

  3. Babies' gestation

    Measured: 1st April 2012-1st October 2017

  4. Number of reported incidents

    Measured: 1st April 2012-1st October 2017

  5. Admission to NICU

    Measured: 1st April 2012-1st October 2017

  6. Antenatal triage numbers

    Measured: 1st April 2012-1st October 2017

  7. Emergency caesarean deliveries

    Measured: 1st April 2012-1st October 2017

  8. Induced deliveries

    Measured: 1st April 2012-1st October 2017

  9. Birthweight

    Measured: 1st April 2012-1st October 2017

  10. Birthweight centile

    Using GROW-Centile software

    Measured: 1st April 2012-1st October 2017

  11. Spontaneous deliveries

    Measured: 1st April 2012-1st October 2017

  12. Caesarean deliveries

    Measured: 1st April 2012-1st October 2017

  13. Instrumental deliveries

    Measured: 1st April 2012-1st October 2017

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2017
  2. Study start10 Jul 2017
  3. Primary completion28 Feb 2018
  4. Study completion5 Jul 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
4,952 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03231007
Sponsor's protocol ID
R04666
Acronym
SPiRE
Status last verified
Dec 2018
First submitted
6 Jul 2017
Last updated
4 Dec 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Office of National Statistics. Characteristics of birth 1, England and Wales, 2013. London: ONS, 2014.

  • Flenady V, Wojcieszek AM, Middleton P, Ellwood D, Erwich JJ, Coory M, Khong TY, Silver RM, Smith GCS, Boyle FM, Lawn JE, Blencowe H, Leisher SH, Gross MM, Horey D, Farrales L, Bloomfield F, McCowan L, Brown SJ, Joseph KS, Zeitlin J, Reinebrant HE, Cacciatore J, Ravaldi C, Vannacci A, Cassidy J, Cassidy P, Farquhar C, Wallace E, Siassakos D, Heazell AEP, Storey C, Sadler L, Petersen S, Froen JF, Goldenberg RL; Lancet Ending Preventable Stillbirths study group; Lancet Stillbirths In High-Income Countries Investigator Group. Stillbirths: recall to action in high-income countries. Lancet. 2016 Feb 13;387(10019):691-702. doi: 10.1016/S0140-6736(15)01020-X. Epub 2016 Jan 19.

    PubMed 26794070
  • Manktelow BN, S.L., Seaton SE, Hyman-Taylor P, Kurinczuk JJ, Field DJ. MBRRACE-UK Perinatal Mortality Surveillance Report, UK Perinatal Deaths for Births from Janurary to December 2014. Leicester: The Infant Mortality and Morbidity Studies, Department of Health Sciences, University of Leicester, 2016.

  • Draper ES, K.J., Kenyon S (Eds) on behalf of MBRRACE-UK, MBRRACE-UK Perinatal Confidential Enquiry. Term, singleton, normally formed, antepartum stillbirth. Leicester: The Infant Mortality and Morbidity Studies, Department of Health Sciences, Univesity of Leicester. 2015.

  • Widdows K, Roberts SA, Camacho EM, Heazell AEP. Stillbirth rates, service outcomes and costs of implementing NHS England's Saving Babies' Lives care bundle in maternity units in England: A cohort study. PLoS One. 2021 Apr 19;16(4):e0250150. doi: 10.1371/journal.pone.0250150. eCollection 2021.

    PubMed 33872334
  • Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ. 2013 Jan 24;346:f108. doi: 10.1136/bmj.f108.

    PubMed 23349424
  • Marufu TC, Ahankari A, Coleman T, Lewis S. Maternal smoking and the risk of still birth: systematic review and meta-analysis. BMC Public Health. 2015 Mar 13;15:239. doi: 10.1186/s12889-015-1552-5.

    PubMed 25885887
  • RCOG Green-Top Guideline 31: The Investigation and Management of the Small-for-Gestational Ages Fetus. Royal College of Obstetricians and Gynaecologists, 2013.

  • Alfirevic Z, Devane D, Gyte GM. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006066. doi: 10.1002/14651858.CD006066.

    PubMed 16856111
  • Widdows K, Reid HE, Roberts SA, Camacho EM, Heazell AEP. Saving babies' lives project impact and results evaluation (SPiRE): a mixed methodology study. BMC Pregnancy Childbirth. 2018 Jan 30;18(1):43. doi: 10.1186/s12884-018-1672-x.

    PubMed 29378526

Questions about this trial

What is this clinical trial studying?

An observational study of Stillbirth, run by University of Manchester at 20 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 20 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stillbirths (time frame: 1st April 2012-1st October 2017). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03231007, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in